Safety Profile Of Treatments Administered In Covid 19 Infection In Pregnant Women
CLINICA E INVESTIGACION EN GINECOLOGIA Y OBSTETRICIA(2021)
Abstract
SARS-CoV-2 infection has unexpectedly arrived in our society. In pregnant women, the situation has been similar to general population. Some drugs have been used empirically, and obstetricians have to consider whether the same treatments used in the general population were valid for pregnant women with severe disease, according to their safety profile for both the mother and the fetus. There has been a wide experience with the use of hydroxychloroquine and lopinavir/ritonavir in pregnant women. Tocilizumab and interferon beta could be used if benefits exceed risks. There is no experience using remdesivir in pregnancy. (C) 2021 Published by Elsevier Espana, S.L.U.
MoreTranslated text
Key words
SARS-CoV-2, Coronavirus disease, Pregnancy, Drugs, Treatment
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined